Results 91 to 100 of about 58,152 (222)

Molecular Diagnostics Update for the Emerging (If Not Already Widespread) Sexually Transmitted Infection Agent \u3cem\u3eMycoplasma genitalium\u3c/em\u3e: Just About Ready for Prime Time [PDF]

, 2017
Mycoplasma genitalium is an important and emerging agent of sexually transmitted infection in females and males, carrying the potential for postinfection genital tract sequelae.
Erik, Munson
core   +1 more source

Assessing the Impact of Female Genital Mutilation/Cutting on Genital Inflammation and Microbiota Among Kenyan Female Sex Workers

American Journal of Reproductive Immunology, Volume 95, Issue 5, May 2026.
ABSTRACT Problem Female genital mutilation/cutting (FGM/C) is harmful to physical, mental, and reproductive health, though the effect of this practice on a woman's HIV susceptibility is poorly understood. Despite the known associations of FGM/C with short‐term vaginal epithelial damage, neither genital inflammation nor the genital microbiome have been ...
James Pollock, Rachel Liu, Elizabeth Rwenji, Evelyne Orobi, Suji Udayakumar, Sanja Huibner, Mary Kung'u, Rhoda Kabuti, Hellen Babu, Maisha Fiti Study Champions, Erastus Irungu, Pauline Ngurukiri, Peter Muthoga, Wendy Adhiambo, Helen A. Weiss, Janet Seeley, Tanya Abramsky, Joshua Kimani, Tara S. Beattie, Rupert Kaul   +19 more
wiley   +1 more source

Analysis of antibiotic resistance of 438 clinical isolates of Neisseria gonorrhoeae obtained from 2018 to 2022

Pifu-xingbing zhenliaoxue zazhi
Objective To summarize the surveillance results of antibiotic resistance of Neisseria gonorrhoeae to 7 antibiotics (penicillin G, tetracycline, ciprofloxacin, spectinomycin, cefixime, ceftriaxone and Azithromycin) in Panyu District, Guangzhou, from 2018 ...
Huanxi LIANG, Lichang LAO, Jingzhong LI, Xiaoneng HE, Yunyi HUANG, Jianyu GUO, Chixing GUO   +6 more
doaj   +1 more source

Novel drugs approved by the EMA, the FDA and the MHRA in 2025: A year in review

British Journal of Pharmacology, Volume 183, Issue 9, Page 1779-1813, May 2026.
Abstract In the 2025 novel drug mini‐review, one can take a full measure of the ingenuity that underlies current drug design and development, despite the year's smaller harvest (46 novel drugs) compared to 2024 (53) and 2023 (70). 54% of the novel drugs are first‐in‐class (FIC).
Andreas Papapetropoulos, Stavros Topouzis, Steve P. H. Alexander, Miriam M. Cortese‐Krott, Zsuzsanna Helyes, Kirill Martemyanov, Claudio Mauro, Nithyanandan Nagercoil, Reynold A. Panettieri Jr, Hemal H. Patel, Rainer Schulz, Barbara Stefanska, Gary J. Stephens, Nathalie Vergnolle, Xin Wang, Stephen Ward, Péter Ferdinandy   +16 more
wiley   +1 more source

The Landscape of Realized Homologous Recombination in Pathogenic Bacteria [PDF]

, 2015
Recombination enhances the adaptive potential of organisms by allowing genetic variants to be tested on multiple genomic backgrounds. Its distribution in the genome can provide insight into the evolutionary forces that underlie traits, such as the ...
Didelot, X, Falush, D, Jolley, KA, Kobayashi, I, Maiden, MCJ, Sheppard, SK, Yahara, K   +6 more
core   +2 more sources

Bacterial Infections Role in Gynecological Cancers Development: Narrative Review

Cancer Reports, Volume 9, Issue 4, April 2026.
ABSTRACT Background Gynecological cancers are among the most common cancers in women that affect female reproductive organs. The most common gynecological cancers are ovarian, cervical, uterine/endometrial, vaginal, and vulvar cancer. Women's reproductive organs have a dynamic and relative microbial balance.
Robab Azargun, Maryam Azargoon, Zahra Asefy, Mina Yekani, Vahideh Tarhriz, Fatemeh Yeganeh, Mohammad Yousef Memar, Shirin Eyvazi   +7 more
wiley   +1 more source

Measurement and predictors of adherence in a trial of HSV suppressive therapy in Tanzania.

, 2009
This study estimates adherence and identifies predictors of good adherence among 1305 Tanzanian women participating in a randomised, double-blind, placebo-controlled trial of HSV suppressive therapy to reduce HIV incidence or genital HIV shedding.
Baisley, Kathy, Changalucha, John, Clayton, Tim, Hambleton, Ian, Hayes, Richard J, Mugeye, Kokugonza, Ross, David A, Rusizoka, Mary, Tanton, Clare, Watson-Jones, Deborah, Weiss, Helen A   +10 more
core   +1 more source

Predominant porB1A and porB1B genotypes and correlation of gene mutations with drug resistance in Neisseria gonorrhoeae isolates in Eastern China [PDF]

, 2010
Background Variations of porB1A and porB1B genes and their serotypes exist in Neisseria gonorrhoeae isolates from different geographical areas, and some site mutations in the porB1B gene correlate with drug resistance.
Aihua Sun, Xingli Fan, Ye Gu, Peng Du, Renxian Tang, Yafei Mao, Xuai Lin, Jie Yan   +7 more
core   +1 more source

Bacterial Extracellular Vesicles in Biomedical Research and Clinical Translation

Microbial Biotechnology, Volume 19, Issue 4, April 2026.
Bacterial membrane vesicle biomedical applications. ABSTRACT Bacterial Extracellular Vesicles (bEVs) are lipid (single‐ or double‐bilayer) nanostructures secreted by virtually all bacteria that play fundamental roles in intercellular communication and have emerged as powerful, multifunctional tools in biomedicine. Their intrinsic ability to encapsulate
Alejandro Arce‐Rodríguez, Javier De la Peña Noya, José Manuel Borrero‐de Acuña   +2 more
wiley   +1 more source

NsrR from Streptomyces coelicolor is a nitric oxide-sensing [4Fe-4S] cluster protein with a specialized regulatory function [PDF]

, 2015
The Rrf2 family transcription factor NsrR controls expression of genes in a wide range of bacteria in response to nitric oxide (NO). The precise form of the NO-sensing module of NsrR is the subject of controversy because NsrR proteins containing either ...
Al-Bassam, Mahmoud, Crack, Jason, Cramer, Stephen, Dodd, Erin, Hamilton, Christopher, Holland, Ashley, Hutchings, Matthew, Johnson, Michael, Kamali, Saeed, Knowles, Felicity, Le Brun, Nick, Munnoch, John Tyson, Thomson, Andrew   +12 more
core   +1 more source